Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1990 Jun;61(6):813–820. doi: 10.1038/bjc.1990.183

Glycosphingolipid expression on murine L1-fibrosarcoma cells: analysis of clonal in vivo and in vitro selected sublines with different lung colonisation potential.

F G Hanisch 1, J Sölter 1, V Jansen 1, A Lochner 1, J Peter-Katalinic 1, G Uhlenbruck 1
PMCID: PMC1971703  PMID: 2372482

Abstract

The patterns of acidic and neutral glycosphingolipids (GSLs) were examined in a syngeneic tumour system in Balb/c mice consisting of closely related cell lines with different colonisation potentials directed to the murine lungs (in vivo selected highly metastatic sublines of L1-fibrosarcoma cells and their WGA-resistant mutants with low metastatic potential). GSLs were analysed by high-performance thin-layer chromatography and structurally identified by fast atom bombardment mass spectrometry combined with compositional analyses and exo-glycosidase digestion. The results suggest that highly metastatic sublines L1-LM and L1-LM12 derived by in vivo selection from mouse fibrosarcoma cells (cell line L1) exhibit a drastic increase of polar ganglioside expression and a restriction to globo-series GSLs. Contrasting with this the low metastatic mutant cells (L1-LM13WGA) express a reduced portion of acidic GSLs and exhibit a shift to less polar ganglioside components. Total cellular and plasma membrane-integrated GSLs were demonstrated to exhibit largely identical patterns. Concomitant with a significant decrease in LacCer expression a substantial reduction of GM2 and a complete lack of GM3 expression can be assigned to the highly metastatic sublines of L1-cells. On the other hand, the more polar gangliosides GM1a and, to an even greater extent, GD1a (exceeding 70% of total gangliosides) accumulate on L1-LM and their clonal sublines. The shift to acidic GSLs of higher polarity is less pronounced on the low metastatic WGA-resistant mutant cells (L1-LM13WGA) showing a preponderance of GM1a. The portion of GD1a within the fractions of acidic GSLs does not correspond to the cellular activities of CMP-NeuAc/GM1 (alpha 2-3) sialyltransferase measured for high and low metastatic cell variants. Total sialic acid content of the various cell lines differs, but is not associated with the metastatic potential. Gangliosides on L1-cells exhibit a significant substitution of N-glycolyl for N-acetylneuraminic acid (13%) compared to their metastatic sublines and to mutant cells (less than 1%). A conversion of surface exposed GD1a to GM1a on membranes of metastatic cells by in situ treatment with Vibrio cholerae sialidase is associated with a significant reduction of tumour cell colonisation directed to the murine lungs.

Full text

PDF
813

Images in this article

815Figure 1
on p.815
816Figure 2
on p.816
818Figure 3
on p.818

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AMINOFF D. Methods for the quantitative estimation of N-acetylneuraminic acid and their application to hydrolysates of sialomucoids. Biochem J. 1961 Nov;81:384–392. doi: 10.1042/bj0810384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Chaplin M. F. A rapid and sensitive method for the analysis of carbohydrate components in glycoproteins using gas-liquid chromatography. Anal Biochem. 1982 Jul 1;123(2):336–341. doi: 10.1016/0003-2697(82)90455-9. [DOI] [PubMed] [Google Scholar]
  3. Dennis J. W., Carver J. P., Schachter H. Asparagine-linked oligosaccharides in murine tumor cells: comparison of a WGA-resistant (WGAr) nonmetastatic mutant and a related WGA-sensitive (WGAs) metastatic line. J Cell Biol. 1984 Sep;99(3):1034–1044. doi: 10.1083/jcb.99.3.1034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dennis J., Donaghue T., Florian M., Kerbel R. S. Apparent reversion of stable in vitro genetic markers detected in tumour cells from spontaneous metastases. Nature. 1981 Jul 16;292(5820):242–245. doi: 10.1038/292242a0. [DOI] [PubMed] [Google Scholar]
  5. HAKOMORI S. A RAPID PERMETHYLATION OF GLYCOLIPID, AND POLYSACCHARIDE CATALYZED BY METHYLSULFINYL CARBANION IN DIMETHYL SULFOXIDE. J Biochem. 1964 Feb;55:205–208. [PubMed] [Google Scholar]
  6. Irimura T., Gonzalez R., Nicolson G. L. Effects of tunicamycin on B16 metastatic melanoma cell surface glycoproteins and blood-borne arrest and survival properties. Cancer Res. 1981 Sep;41(9 Pt 1):3411–3418. [PubMed] [Google Scholar]
  7. Kijima-Suda I., Miyamoto Y., Toyoshima S., Itoh M., Osawa T. Inhibition of experimental pulmonary metastasis of mouse colon adenocarcinoma 26 sublines by a sialic acid:nucleoside conjugate having sialyltransferase inhibiting activity. Cancer Res. 1986 Feb;46(2):858–862. [PubMed] [Google Scholar]
  8. Kubo H., Hoshi M. Elimination of silica gel from gangliosides by using a reversed-phase column after preparative thin-layer chromatography. J Lipid Res. 1985 May;26(5):638–641. [PubMed] [Google Scholar]
  9. Laferté S., Fukuda M. N., Fukuda M., Dell A., Dennis J. W. Glycosphingolipids of lectin-resistant mutants of the highly metastatic mouse tumor cell line, MDAY-D2. Cancer Res. 1987 Jan 1;47(1):150–159. [PubMed] [Google Scholar]
  10. Nicolson G. L. Cell surface molecules and tumor metastasis. Regulation of metastatic phenotypic diversity. Exp Cell Res. 1984 Jan;150(1):3–22. doi: 10.1016/0014-4827(84)90696-7. [DOI] [PubMed] [Google Scholar]
  11. Poste G., Nicolson G. L. Arrest and metastasis of blood-borne tumor cells are modified by fusion of plasma membrane vesicles from highly metastatic cells. Proc Natl Acad Sci U S A. 1980 Jan;77(1):399–403. doi: 10.1073/pnas.77.1.399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Rosenfelder G., Young W. W., Jr, Hakomori S. I. Association of the glycolipid pattern with antigenic alterations in mouse fibroblasts transformed by murine sarcoma virus. Cancer Res. 1977 May;37(5):1333–1339. [PubMed] [Google Scholar]
  13. Saito T., Hakomori S. I. Quantitative isolation of total glycosphingolipids from animal cells. J Lipid Res. 1971 Mar;12(2):257–259. [PubMed] [Google Scholar]
  14. Schwartz R., Kniep B., Müthing J., Mühlradt P. F. Glycoconjugates of murine tumor lines with different metastatic capacities. II. Diversity of glycolipid composition. Int J Cancer. 1985 Nov 15;36(5):601–607. doi: 10.1002/ijc.2910360514. [DOI] [PubMed] [Google Scholar]
  15. Schwartz R., Schirrmacher V., Mühlradt P. F. Glycoconjugates of murine tumor lines with different metastatic capacities. I. Differences in fucose utilization and in glycoprotein patterns. Int J Cancer. 1984 Apr 15;33(4):503–509. doi: 10.1002/ijc.2910330414. [DOI] [PubMed] [Google Scholar]
  16. Smets L. A., van Rooy H., Homburg C. Cell communication and membrane glycoprotein in junction-defective L cells and somatic cell hybrids. Exp Cell Res. 1979 Oct 1;123(1):87–94. doi: 10.1016/0014-4827(79)90424-5. [DOI] [PubMed] [Google Scholar]
  17. Springer G. F., Cheingsong-Popov R., Schirrmacher V., Desai P. R., Tegtmeyer H. Proposed molecular basis of murine tumor cell-hepatocyte interaction. J Biol Chem. 1983 May 10;258(9):5702–5706. [PubMed] [Google Scholar]
  18. Steck P. A., North S. M., Nicolson G. L. Purification and partial characterization of a tumour-metastasis-associated high-Mr glycoprotein from rat 13762NF mammary adenocarcinoma cells. Biochem J. 1987 Mar 15;242(3):779–787. doi: 10.1042/bj2420779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Uhlenbruck G., Beuth J., Oette K., Roszkowski W., Ko H. L., Pulverer G. Prevention of experimental liver metastases by arabinogalactan. Naturwissenschaften. 1986 Oct;73(10):626–627. doi: 10.1007/BF00368781. [DOI] [PubMed] [Google Scholar]
  20. Uhlenbruck G., Beuth J., Weidtman V. Liver lectins: mediators for metastases? Experientia. 1983 Nov 15;39(11):1314–1315. doi: 10.1007/BF01990389. [DOI] [PubMed] [Google Scholar]
  21. Yeatman T. J., Bland K. I., Copeland E. M., 3rd, Kimura A. K. Tumor cell-surface galactose correlates with the degree of colorectal liver metastasis. J Surg Res. 1989 Jun;46(6):567–571. doi: 10.1016/0022-4804(89)90021-8. [DOI] [PubMed] [Google Scholar]
  22. Yogeeswaran G., Gronberg A., Hansson M., Dalianis T., Kiessling R., Welsh R. M. Correlation of glycosphingolipids and sialic acid in YAC-1 lymphoma variants with their sensitivity to natural killer-cell-mediated lysis. Int J Cancer. 1981 Oct 15;28(4):517–526. doi: 10.1002/ijc.2910280419. [DOI] [PubMed] [Google Scholar]
  23. Yogeeswaran G., Salk P. L. Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell lines. Science. 1981 Jun 26;212(4502):1514–1516. doi: 10.1126/science.7233237. [DOI] [PubMed] [Google Scholar]
  24. Yogeeswaran G., Stein B. S. Glycosphingolipids of metastatic variant RNA virus-transformed nonproducer Balb/3T3 cell lines: altered metabolism and cell surface exposure. J Natl Cancer Inst. 1980 Nov;65(5):967–975. [PubMed] [Google Scholar]
  25. Yu R. K., Ledeen R. W. Gangliosides of human, bovine, and rabbit plasma. J Lipid Res. 1972 Sep;13(5):680–686. [PubMed] [Google Scholar]
  26. Yu R. K., Ledeen R. W. Gas--liquid chromatographic assay of lipid-bound sialic acids: measurement of gangliosides in brain of several species. J Lipid Res. 1970 Nov;11(6):506–516. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES